times
Username or Email Address
Password
Remember Me
Don't have an account yet? Click HERE to register for FREE.
Biotech company Alv B AS aims to form a group of UK veterinarian investors with a view to beginning clinical trials for canine cancer vaccine Alvacan 4000 in early 2023.
